Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Change in Cash (2024 - 2025)

Historic Change in Cash for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to $13.3 million.

  • Kura Oncology's Change in Cash rose 21042.59% to $13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.8 million, marking a year-over-year change of. This contributed to the annual value of $187.1 million for FY2024, which is 139207.4% up from last year.
  • Per Kura Oncology's latest filing, its Change in Cash stood at $13.3 million for Q3 2025, which was up 21042.59% from $30.7 million recorded in Q2 2025.
  • Over the past 5 years, Kura Oncology's Change in Cash peaked at $175.0 million during Q4 2024, and registered a low of -$173.2 million during Q1 2025.